171 related articles for article (PubMed ID: 38503490)
1. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
Wang Z; Van Faassen M; Groen H; Cantineau AEP; Van Oers A; Van der Veen A; Hawley JM; Keevil BG; Kema IP; Hoek A
Hum Reprod; 2024 May; 39(5):1078-1088. PubMed ID: 38503490
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.
van Oers AM; Groen H; Mutsaerts MA; Burggraaff JM; Kuchenbecker WK; Perquin DA; Koks CA; van Golde R; Kaaijk EM; Schierbeek JM; Oosterhuis GJ; Broekmans FJ; Vogel NE; Land JA; Mol BW; Hoek A;
Hum Reprod; 2016 Dec; 31(12):2704-2713. PubMed ID: 27798042
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of lifestyle intervention in obese infertile women.
van Oers AM; Mutsaerts MAQ; Burggraaff JM; Kuchenbecker WKH; Perquin DAM; Koks CAM; van Golde R; Kaaijk EM; Schierbeek JM; Klijn NF; van Kasteren YM; Land JA; Mol BWJ; Hoek A; Groen H;
Hum Reprod; 2017 Jul; 32(7):1418-1426. PubMed ID: 28486704
[TBL] [Abstract][Full Text] [Related]
4. In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation.
Kuchenbecker WK; Groen H; van Asselt SJ; Bolster JH; Zwerver J; Slart RH; Vd Jagt EJ; Muller Kobold AC; Wolffenbuttel BH; Land JA; Hoek A
Hum Reprod; 2011 Sep; 26(9):2505-12. PubMed ID: 21771766
[TBL] [Abstract][Full Text] [Related]
5. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.
Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M;
Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200
[TBL] [Abstract][Full Text] [Related]
7. The role of PCOS in mental health and sexual function in women with obesity and a history of infertility.
Karsten MDA; Wekker V; Groen H; Painter RC; Mol BWJ; Laan ETM; Roseboom TJ; Hoek A
Hum Reprod Open; 2021; 2021(4):hoab038. PubMed ID: 34877412
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle intervention prior to IVF does not improve embryo utilization rate and cumulative live birth rate in women with obesity: a nested cohort study.
Wang Z; Groen H; Van Zomeren KC; Cantineau AEP; Van Oers A; Van Montfoort APA; Kuchenbecker WKH; Pelinck MJ; Broekmans FJM; Klijn NF; Kaaijk EM; Mol BWJ; Hoek A; Van Echten-Arends J
Hum Reprod Open; 2021; 2021(4):hoab032. PubMed ID: 34557597
[TBL] [Abstract][Full Text] [Related]
9. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
11. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
13. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
14. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.
Balen AH; Morley LC; Misso M; Franks S; Legro RS; Wijeyaratne CN; Stener-Victorin E; Fauser BC; Norman RJ; Teede H
Hum Reprod Update; 2016 Nov; 22(6):687-708. PubMed ID: 27511809
[TBL] [Abstract][Full Text] [Related]
15. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
16. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
17. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.
Kissell KA; Danaher MR; Schisterman EF; Wactawski-Wende J; Ahrens KA; Schliep K; Perkins NJ; Sjaarda L; Weck J; Mumford SL
Hum Reprod; 2014 Aug; 29(8):1764-72. PubMed ID: 24925522
[TBL] [Abstract][Full Text] [Related]
18. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
